(Q34616652)

English

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2. (English)

1 reference

Europe PubMed Central

3 August 2017

Maurizio Zangari

11

object named as

Maurizio Zangari

1 reference

Europe PubMed Central

3 August 2017

author name string

Xiaosong Wu

1

1 reference

Europe PubMed Central

3 August 2017

Jumei Shi

2

1 reference

Europe PubMed Central

3 August 2017

Yi Wu

3

1 reference

Europe PubMed Central

3 August 2017

Yi Tao

4

1 reference

Europe PubMed Central

3 August 2017

Jun Hou

5

1 reference

Europe PubMed Central

3 August 2017

Xiuqin Meng

6

1 reference

Europe PubMed Central

3 August 2017

Xiaojing Hu

7

1 reference

Europe PubMed Central

3 August 2017

Ying Han

8

1 reference

Europe PubMed Central

3 August 2017

Wei Jiang

9

1 reference

Europe PubMed Central

3 August 2017

Siyuan Tang

10

1 reference

Europe PubMed Central

3 August 2017

Guido Tricot

12

1 reference

Europe PubMed Central

3 August 2017

Fenghuang Zhan

13

1 reference

Europe PubMed Central

3 August 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

3 August 2017

Cancer Biology and Therapy

1 reference

Europe PubMed Central

3 August 2017

10

1 reference

Europe PubMed Central

3 August 2017

11

1 reference

Europe PubMed Central

3 August 2017

1201-1214

1 reference

Europe PubMed Central

3 August 2017

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Corchorusin-D, a saikosaponin-like compound isolated from Corchorus acutangulus Lam., targets mitochondrial apoptotic pathways in leukemic cell lines (HL-60 and U937).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

The TRAIL apoptotic pathway in cancer onset, progression and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

TRAIL signalling: decisions between life and death.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

The emerging role of arsenic trioxide as an immunomodulatory agent in the management of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

The molecular classification of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

The p53 pathway: positive and negative feedback loops

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Coordinated regulation of life and death by RB.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Arsenicals in hematologic cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Diagnosis, prognosis, and standard treatment of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

7 July 2018

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

Clinical and biologic implications of recurrent genomic aberrations in myeloma

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.

1 reference

https://api.crossref.org/works/10.4161%2FCBT.10.11.13669

21 January 2018

The molecular dynamics of MDM2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

26 October 2018

Effects of arsenic trioxide on cell cycle and expression of cyclin dependent kinase inhibitors of multiple myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

26 October 2018

Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047108

26 October 2018

Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20953137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20953137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide induces p53-dependent apoptotic signals in myeloma cells with SiRNA-silenced p53: MAP kinase pathway is preferentially activated in cells expressing inactivated p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/20953137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypodiploidy is a major prognostic factor in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20953137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/CBT.10.11.13669

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34616652&oldid=1954483870"